About Digital Therapeutics
Digital Therapeutics is a private company based in New York, New York. It has reported $123,638,998 raised in four offerings on Form D since March 2020. Its chief executive is Yusuf Sherwani.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 21, 2023 | Apr 11, 2024 | $50,499,903fully sold | 10 | $5.0M | EquityRule 506(b) | Form D ↗ |
| Jul 27, 2022 | Aug 11, 2022 | $11,499,981of $15.2M target | 2 | $5.7M | EquityRule 506(b) | Form D ↗ |
| Jul 14, 2021 | Jul 29, 2021 | $49,499,929fully sold | 6 | $8.2M | EquityRule 506(b) | Form D ↗ |
| Jan 30, 2020 | Mar 24, 2020 | $12,139,185of $13.7M target | 31 | $391K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $123,638,998 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Digital Therapeutics's Form D filed Apr 11, 2024.
YS
Yusuf Sherwani
Chief Executive Officer and director
GM
Gabriel Mecklenburg
Director
WG
Will Gibbs
Director
MM
Maria Maras
Director
SS
Sarim Siddiqui
Executive officer and director
BB
Ben Blume
Director
MA
Maroof Ahmed
Executive officer and director
Earlier filings also listed Christian Scherrer (director, last listed Aug 2022).